Acea biosciences:1105804 [18-005492] - acea biosciences xcelligence rtca cardioecr instrument. Points of contact: WEI zheng, jennifer kouznetsova, and angel taylor.
Ended Purchase Order Awarded
- Contract number
- 75N95018P00599
- Awardee
-
Acea Biosciences, Inc. UEI KDBTPQNGNYH5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,900
Award facts
- Opportunity
-
- ACEA Biosciences xCELLigence RTCA CardioECR instrument, or Brand Name Equal Item Solicitation · NIHDA201800513 · Posted Aug 29, 2018
- Contract value 100% obligated
- $149,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $149,900.00 firm fixed-price purchase order contract to Acea Biosciences, Inc., a small business, for the supply of one xCELLigence RTCA CardioECR instrument or an equivalent brand name equal item. This specialized equipment is used for real-time measurement of cardiomyocyte contractility, viability, and electrical activity to support NCATS' research efforts. The contract includes requirements for delivery, installation, training, and technical capabilities of the instrument. The original solicitation was issued as a total small business set-aside under simplified acquisition procedures.
Quick answers
Who was awarded contract 75N95018P00599?
75N95018P00599 was awarded to Acea Biosciences, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 6, 2018.
How much is contract 75N95018P00599 worth?
The government has obligated $149,900 on 75N95018P00599.
Which agency awarded contract 75N95018P00599?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018P00599, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95018P00599 competed?
The extent of competition for 75N95018P00599 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award